Login
$NGNE
$26.99 +$3.45 (14.66%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Rachel McMinn Also a director
Executive Chair and Chief Executive Officer
53 Not stated Not stated $3,209,553
Christine Mikail Cvijic
President and Chief Financial Officer
48 Since 2023
3 years
Not stated $2,754,458
Julie Jordan
Chief Medical Officer
54 Since 2024
2 years
Not stated $1,472,307
Stuart Cobb
Chief Scientific Officer
56 Since 2023
3 years
Not stated Not reported
Christina Shafer
Chief Commercial Officer
Title from the Form 4 dated May 5, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
5 of 6
stated in the proxy
Average tenure
3.8 years
from year joined
CEO also chairs the board
Yes
Rachel McMinn, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Rachel McMinn, Ph.D.
53 2023
3 years
Not independent None stated None stated Paid as CEO
Cory Freedland, Ph.D.
50 2023
3 years
Independent
Audit Committee · Chair
None stated Not stated
Robert Baffi, Ph.D.
71 2023
3 years
Independent
Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated Not stated
Rohan Palekar
60 2022
4 years
Independent
Audit Committee Compensation Committee · Chair
None stated $244,484
Sarah B. Noonberg, M.D., Ph.D.
58 2019
7 years
Independent None stated None stated Not stated
Robert Keith Woods
58 2023
3 years
Independent
Audit Committee Nominating and Corporate Governance Committee
TScan Therapeutics, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support